Cytotoxicity evaluation of soft contact lens care solutions on human conjunctival fibroblasts

Ophthalmologica

Volumn 218, Issue 6, 2004, Pages 385-389

  Horwath Winter, J ^a   Simon, M ^a   Kolli H ^a   Trummer, G ^a   Schmut, O ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Conjunctival cells; Contact lens care solutions; Cytotoxicity

Indexed keywords

CONTACT LENS SOLUTION;

ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL VIABILITY; CONJUNCTIVA; CONTROLLED STUDY; CYTOTOXICITY TEST; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; SOFT CONTACT LENS; STATISTICAL SIGNIFICANCE;

CELL SURVIVAL; CELLS, CULTURED; CONJUNCTIVA; CONTACT LENS SOLUTIONS; CONTACT LENSES, HYDROPHILIC; FIBROBLASTS; FORMAZANS; HUMANS; MITOCHONDRIA; TETRAZOLIUM SALTS;

EID: 9244263070     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080941     Document Type: Article

References (39)

1. Stamler JF: The complications of contact lens wear. Curr Opin Ophthalmol 1998;9:66-71.
2. Allansmith MR, Korb DR, Greiner JV, Henriquez AS, Simon MA, Finnemore VM: Giant papillary conjunctivitis in contact lens wearers. Am J Ophthalmol 1977;85:697-708.
3. Allansmith MR, Korb DR, Greiner JV: Giant papillary conjunctivitis induced by hard or soft contact lens wear: Quantitative histology. Ophthalmology 1978;85:766-778.
4. Sendele DD, Kenyon KR, Mobilia EF, Rosenthal P, Steinert R, Hann LA: Superior limbic keratoconjunctivitis in contact lens wearer. Ophthalmology 1983;90:616-622.
5. Wilson FM: Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol 1979;24:57-88.
6. Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, Bechetoille A: Ocular surface inflammatory changes induced by topical antiglaucoma drugs: Human and animal studies. Ophthalmology 1999;106:556-563.
7. Mietz H, Niesen U, Krieglstein GK: The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol 1994;232:561-565.
8. Becquet F, Goldschild M, Moldovan MS, Ettaiche M, Gastaud P, Baudouin C: Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res 1998;17:419-425.
9. De Saint Jean M, Brignole F, Bringuier A-F, Bauchet A, Feldmann G, Baudouin C: Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999;40:619-630.
10. Gasset AR, Ishil Y, Kaufman HE, Miller T: Cytotoxicity of ophthalmic preservatives. Am J Ophthalmol 1974;78:98-105.
11. Pfister RR, Burstein N: The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: A scanning electron microscope study. Invest Ophthalmol 1976;15:246-259.
12. Burstein NL: Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 1980;25:15-30.
13. Burstein NL: Preservative alteration of corneal permeability in humans and rabbits. Invest Ophthalmol Vis Sci 1984;25:1453-1457.
14. Chou A, Hori S, Takase M: Ocular toxicity of beta-blockers and benzalkonium chloride in pigmented rabbits: Electrophysiological and morphological studies. Jpn J Ophthalmol 1985;29:13-23.
15. Collin HB: Ultrastructural changes to corneal stromal cells due to ophthalmic preservatives. Acta Ophthalmol 1986;64:72-78.
16. Ramselaar JA, Boot JP, van Haeringen NJ, van Best JA, Oosterhuis JA: Corneal epithelial permeability after instillation of ophthalmic solutions containing local anaesthetics and preservatives. Curr Eye Res 1988;7:947-950.
17. Green K, Johnson RE, Chapman JM, Nelson E, Cheeks L: Preservative effects on the healing rate of rabbit corneal epithelium. Lens Eye Toxic Res 1989;6:37-41.
18. Lazarus HM, Imperia PS, Botti RE, Mack RJ, Lass JH: An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents. Lens Eye Toxic Res 1989;6:59-85.
19. Durand-Cavagna G, Delort P, Duprat P, Bailly Y, Plazonnet B, Gordon LR: Corneal toxicity studies in rabbits and dogs with hydroxyethyl cellulose and benzalkonium chloride. Fundam Appl Toxicol 1989;13:500-508.
20. Brewitt H: Scanning electron microscopic study on local cornea tolerance of beta-blocker eye drops with and without preservatives. Ophthalmologica 1990;201:152-161.
21. Lopez Bernal D, Ubels JL: Quantitative evaluation of the corneal epithelial barrier: Effect of artificial tears and preservatives. Curr Eye Res 1991;10:645-656.
22. Ichijima H, Petroll WM, Jester JV, Cavanagh HD: Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea 1992;11:221-225.
23. Tripathi BJ, Tripathi RC, Kolli SP: Cytotoxicity of ophthalmic preservatives on human corneal epithelium. Lens Eye Toxic Res 1992;9:361-375.
24. Pande M, Ghanchi F: The role of preservatives in the conjunctival toxicity of subconjunctival gentamicin injection. Br J Ophthalmol 1992;76:235-237.
25. De Jong C, Stolwijk T, Kuppens E, de Keizer R, van Best J: Topical timolol with and without benzalkonium chloride: Epithelial permeability and autofluorescence of the cornea in glaucoma. Graefes Arch Clin Exp Ophthalmol 1994;232:221-224.
26. Doughty MJ: Acute effects of chlorobutanol- or benzalkonium chloride-containing artificial tears on the surface features of rabbit corneal epithelial cells. Optom Vis Sci 1994;71:562-572.
27. Grant RL, Acosta D: Prolonged adverse effects of benzalkonium chloride and sodium dodecyl sulfate in a primary culture system of rabbit corneal epithelial cells. Fundam Appl Toxicol 1996;33:71-82.
28. Furrer P, Mayer JM, Plazonnet B, Gurny R: Ocular tolerance of preservatives on the murine cornea. Eur J Pharm Biopharm 1999;47:105-112.
29. Debbasch C, Brignole F, Pesella PJ, Warnet JM, Rat P, Baudouin C: Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001;42:642-652.
30. Adriaens E, Dierckens K, Bauters TG, Nelis HJ, van Goethem F, Vanparys P, Remon JP: The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs. Pharm Res 2001;18:937-942.
31. Pham XT, Huff JW: Cytotoxicity evaluation of multipurpose contact lens solutions using an in vitro test battery. CLAO J 1999;25:28-35.
32. Mowrey-McKee M, Sills A, Wright A: Comparative cytotoxicity potential of soft contact lens care regimens. CLAO J 2002;28:160-164.
33. Vaughan JS, Porter DA: A new in vitro method for assessing the potential toxicity of soft contact lens care solutions. CLAO J 1993;19:54-57.
34. Gong X, Zhong X: Cytotoxicity of contact lens care solution to human corneal epithelium in vitro. Yan Ke Xue Bao 1998;14:45-47.
35. Mosmann T: Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
36. Joshi A: Microparticulates for ophthalmic drug delivery. J Ocul Pharmacol 1994,10:29-45.
37. Lemp MA: Report of the National Eye Institute: Industry workshop on clinical trials in dry eyes. CLAO J 1995;21:222-232.
38. Schmut O, Faulborn J, Trummer G: Quantifying the damage to conjunctival and corneal cell cultures caused by UV light using CASY. A method for reducing animal experiments. Ophthalmologe 1999;96:375-381.
39. Frantz A, Becker J: Etablierung humaner, konjunktivaler Fibroblastenkulturen als Testsystem zur Beurteilung von Ophthalmika. Klin Monatsbl Augenheilkd 1996;208:181-187.